Nasdaq, Inc. logo

Nasdaq, Inc. (NAQ)

Market Closed
6 Jun, 20:00
73. 45
+0.31
+0.42%
- Market Cap
24.55 P/E Ratio
0.88% Div Yield
0 Volume
2.77 Eps
73.14
Previous Close
Day Range
73.45 73.45
Year Range
54.24 81.34
Earnings results expected in 46 days

Summary

NAQ closed yesterday higher at €73.45, an increase of 0.42% from Thursday's close, completing a monthly increase of 9.58% or €6.42. Over the past 12 months, NAQ stock lost -1.29%.
NAQ pays dividends to its shareholders, with the most recent payment made on Mar 28, 2025. The next announced payment will be in In 2 weeks on Jun 27, 2025 for a total of €0.27.
The last earnings report, released on Apr 23, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Jul 23, 2025.
Nasdaq, Inc. has completed 1 stock splits, with the recent split occurring on Aug 29, 2022.
The company's stock is traded on 11 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).
Want to track NAQ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

NAQ Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.
QQA: New Option Strategy ETF In The Nasdaq 100

QQA: New Option Strategy ETF In The Nasdaq 100

The Invesco QQQ Income Advantage ETF offers an 8.63% yield from option strategies in the Nasdaq 100. QQA has 3/4 of assets in Nasdaq 100 stocks and delegates option income generation to equity-linked notes. QQA's short track record shows a total return nearly matching QQQ, but the price return is flat.

Seekingalpha | 6 hours ago
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Compensation Committee of Gossamer's Board of Directors approved the grant, effective June 5th, 2025, to three non-executive employees of non-qualified stock op.

Businesswire | 1 day ago
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 71,275 shares of common stock. Awards were made to seven new employees of the Company. The awards were granted as an inducement material to the new employees becoming employees of the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and have been approved by the Company's Compensation Committ.

Businesswire | 1 day ago

Nasdaq, Inc. Dividends

Nasdaq, Inc. logo
NAQ 2 months ago
Other
€0.21 Per Share
Nasdaq, Inc. logo
NAQ 6 months ago
Other
€0.21 Per Share
Nasdaq, Inc. logo
NAQ 8 months ago
Other
€0.21 Per Share
Nasdaq, Inc. logo
NAQ 11 months ago
Other
€0.21 Per Share
Nasdaq, Inc. logo
NAQ 13 Mar 2024
Other
€0.19 Per Share

Nasdaq, Inc. Earnings

23 Jul 2025 (46 Days) Date
-
Cons. EPS
-
EPS
23 Apr 2025 Date
-
Cons. EPS
-
EPS
29 Jan 2025 Date
-
Cons. EPS
-
EPS
24 Oct 2024 Date
-
Cons. EPS
-
EPS
16 Oct 2024 Date
-
Cons. EPS
-
EPS
Nasdaq, Inc. logo
NAQ 2 months ago
Other
€0.21 Per Share
Nasdaq, Inc. logo
NAQ 6 months ago
Other
€0.21 Per Share
Nasdaq, Inc. logo
NAQ 8 months ago
Other
€0.21 Per Share
Nasdaq, Inc. logo
NAQ 11 months ago
Other
€0.21 Per Share
Nasdaq, Inc. logo
NAQ 13 Mar 2024
Other
€0.19 Per Share
23 Jul 2025 (46 Days) Date
-
Cons. EPS
-
EPS
23 Apr 2025 Date
-
Cons. EPS
-
EPS
29 Jan 2025 Date
-
Cons. EPS
-
EPS
24 Oct 2024 Date
-
Cons. EPS
-
EPS
16 Oct 2024 Date
-
Cons. EPS
-
EPS

Nasdaq, Inc. (NAQ) FAQ

What is the stock price today?

The current price is €73.45.

On which exchange is it traded?

Nasdaq, Inc. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is NAQ.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Jul 23, 2025.

Has Nasdaq, Inc. ever had a stock split?

Nasdaq, Inc. had 1 splits and the recent split was on Aug 29, 2022.

Nasdaq, Inc. Profile

Financial - Data & Stock Exchanges Industry
Financial Services Sector
Ms. Adena T. Friedman CEO
XSTU Exchange
US6311031081 ISIN
US Country
9,377 Employees
14 Mar 2025 Last Dividend
29 Aug 2022 Last Split
1 Jul 2002 IPO Date

Overview

Nasdaq, Inc. is a global technology company that serves capital markets and a variety of other industries, marking its presence worldwide. The company operates across three primary segments: Capital Access Platforms, Financial Technology, and Market Services. Initially known as The NASDAQ OMX Group, Inc., the company underwent a name change to Nasdaq, Inc. in September 2015, continuing its legacy since its inception in 1971. With its headquarters located in New York, New York, Nasdaq, Inc. has been at the forefront of providing innovative financial products, technology solutions, and market services designed to enhance the efficiency and transparency of the capital markets.

Products and Services

  • Capital Access Platforms

    This segment is integral to Nasdaq's offerings, focusing on the distribution of historical and real-time market data. It encompasses developing and licensing Nasdaq-branded indices and financial products, providing investor relations intelligence, governance solutions, ESG solutions, insights, and workflow solutions. It also includes the operation of listing platforms, making it a crucial component for enterprises seeking capital market access and compliance.

  • Financial Technology

    Nasdaq's Financial Technology segment presents a range of solutions aimed at combating financial fraud and enhancing regulatory compliance, including:

    • Verafin: A cloud-based platform designed for the detection, investigation, and reporting of money laundering and financial frauds.
    • Surveillance solutions: A SaaS platform that aids organizations in complying with market rules, regulations, and internal market surveillance policies.
    • AxiomSL: A risk data management and regulatory reporting solution that addresses the complex data and reporting needs of financial institutions.
    • Calypso: A comprehensive front-to-back trading technology solution for financial markets, covering various asset classes.
    This segment caters to a broad spectrum of financial market needs, including trade management and colocation services.

  • Market Platforms

    The Market Platforms segment of Nasdaq, Inc. provides a variety of trading and clearing services across multiple asset classes. These include:

    • Equity derivative trading and clearing
    • Cash equity trading
    • Fixed income and commodities trading and clearing
    • Currency trading services
    Operating a diverse array of exchanges and marketplace facilities, this segment covers derivatives, commodities, cash equity, debt, structured products, and exchange-traded products. It also encompasses the provision of clearing, settlement, and central depository services, reinforcing the backbone of transactional integrity in the global financial market.

Contact Information

Address: 151 West 42nd Street
Phone: 212 401 8700